These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 136282)

  • 21. Cardiac glucosides: correlations among Na+ K+-ATPase, sodium pump and contractility in the guinea pig heart.
    Akera DK; Brody TM; Ku D; Pew CL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(2):185-200. PubMed ID: 4281068
    [No Abstract]   [Full Text] [Related]  

  • 22. [Potential difference generated by Na+, K+-ATPase at an octane-water interface].
    Mirsalikhova NM; Boguslavskiĭ LI; Volkov AG; Tashmukhamedov BA; Umarova FT
    Dokl Akad Nauk SSSR; 1976; 229(6):1473-6. PubMed ID: 134882
    [No Abstract]   [Full Text] [Related]  

  • 23. The biphasic action of cardiac glycosides on the Na+, K+-pump and its relevance in the treatment of heart failure.
    Godfraind T
    Eur Heart J; 1982 Dec; 3 Suppl D():53-7. PubMed ID: 6297911
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides.
    Schwartz A; Grupp G; Wallick E; Grupp IL; Ball WJ
    Prog Clin Biol Res; 1988; 268B():321-38. PubMed ID: 2851810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in cardiac glycoside-Na+,K+-ATPase interaction.
    Wallick ET; Lindenmayer GE; Lane LK; Allen JC; Pitts BJ; Schwartz A
    Fed Proc; 1977 Aug; 36(9):2214-8. PubMed ID: 142025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular mechanisms of the inotropic action of cardiac glycosides].
    Beresewicz A
    Kardiol Pol; 1974; 17(3):267-73. PubMed ID: 4276789
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac sodium, potassium-adenosine triphosphatase as a possible site of adriamycin-induced cardiotoxicity.
    Solomonson LP; Halabrin PR
    Cancer Res; 1981 Feb; 41(2):570-2. PubMed ID: 6256069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the cardiac glycoside inotropic receptor.
    Brody TM; Akera T
    Proc West Pharmacol Soc; 1975; 18():8-13. PubMed ID: 126458
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action mechanism of cardiotonics, with special reference to relationship between cardiac glycosides and electrolytes].
    Saito H; Kawaguchi M; Tanabe T
    Nihon Rinsho; 1969 Apr; 27(4):1202-7. PubMed ID: 4241089
    [No Abstract]   [Full Text] [Related]  

  • 30. Membrane Na+-K+-ATPase and electromechanics of human heart.
    Prasad K
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():91-105. PubMed ID: 4283224
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversible inhibition of (Na+ + K+)-ATPase with a cardiac glycoside.
    Ross CR; Pessah NI
    Eur J Pharmacol; 1975 Aug; 33(1):223-6. PubMed ID: 126168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
    Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Na+-K+-activated adenosine triphosphatase in the transmembrane transport of K+ and Na+: relationships to the inotropic and electrophysiologic effects of digitalis.
    Ten Eick RE; Bassett AL; Okita GT
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():107-17. PubMed ID: 4283204
    [No Abstract]   [Full Text] [Related]  

  • 34. [The mechanism of action of cardiac glycosides].
    Schatzmann HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):12-23. PubMed ID: 4240935
    [No Abstract]   [Full Text] [Related]  

  • 35. Ionic currents in cardiac muscle: a framework for glycoside action.
    Beeler GW
    Fed Proc; 1977 Aug; 36(9):2209-13. PubMed ID: 142024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides.
    Schwartz A; Allen JC; Harigaya S
    J Pharmacol Exp Ther; 1969 Jul; 168(1):31-41. PubMed ID: 4240030
    [No Abstract]   [Full Text] [Related]  

  • 37. [Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K)-active ATPase. Clinical significance and application possibilities].
    Erdmann E; Schoner W
    Verh Dtsch Ges Inn Med; 1974; 80():1075-7. PubMed ID: 4281574
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adhesion of the glycoside molecule to specific binding sites].
    Lüllmann H; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):277-8. PubMed ID: 4242421
    [No Abstract]   [Full Text] [Related]  

  • 39. On the lack of inotropy of cardiac glycosides on skeletal muscle: a comparison of Na+, K+-ATPases from skeletal and cardiac muscle.
    Pitts BJ; Wallick ET; Van Winkle WB; Allen JC; Schwartz A
    Arch Biochem Biophys; 1977 Dec; 184(2):431-40. PubMed ID: 145824
    [No Abstract]   [Full Text] [Related]  

  • 40. [Basis of the active mechanism of cardioactive glycoside].
    Schoner W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():6-18. PubMed ID: 148185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.